SCHEMBL2401094

SCHEMBL2401094

NC(=O)CC[CH]c1cccc(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
PKM P14618 1/20 0.52
HSD17B3 P37058 1/20 0.50
PARP1 P09874 1/20 0.46
SLC6A19 Q695T7 1/20 0.44
BACE1 P56817 1/20 0.44
POLB P06746 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
LMNA P02545 1/20 0.41
CYP2C9 P11712 1/20 0.41
PLEC Q15149 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSD11B1 P28845 1/20 0.40
CYP1B1 Q16678 1/20 0.40
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13358888 0.92 ALDH1A1 (0.52) ALDH1A1PKMHSD17B3PARP1SLC6A19
SCHEMBL13358897 0.90 PKM (0.50) ALDH1A1PKMHSD17B3PARP1SLC6A19
SCHEMBL2401016 0.84 ALDH1A1 (0.55) ALDH1A1PKMHSD17B3PARP1SLC6A19
SCHEMBL5329189 0.80 ALDH1A1 (0.41) ALDH1A1PKMPARP1POLBCYP2D6
SCHEMBL3464493 0.77 KDM4E (0.42) ALDH1A1PKMPOLBCYP1A2CYP2C19
SCHEMBL9955878 0.77 PKM (0.32) PKM
SCHEMBL13358871 0.76 HSD17B3 (0.58) ALDH1A1PKMHSD17B3PARP1SLC6A19
SCHEMBL2399600 0.76 RECQL (0.51) ALDH1A1PKMLMNAMAOB
SCHEMBL13358940 0.74 ALDH1A1 (0.47) ALDH1A1PKMHSD17B3PARP1SLC6A19
SCHEMBL27834763 0.74 HSD17B3 (0.51) ALDH1A1PKMHSD17B3PARP1SLC6A19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285783-B1 INDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2014-05-21 EP disclosed
EP-2297112-B1 PYRAZOLE COMPOUNDS AS CCR1 ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2013-04-03 EP disclosed
US-8293917-B2 Pyrazole compounds as CCR1 antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-10-23 US disclosed
US-8263597-B2 Indazole compounds as CCR1 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-09-11 US disclosed
US-20110294808-A1 Indazole Compounds As CCR1 Receptor Antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-01 US disclosed
US-20110230521-A1 Pyrazole Compounds As CCR1 Antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-22 US disclosed
WO-2009137338-A1 PYRAZOLE COMPOUNDS AS CCR1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294808-A1 Indazole Compounds As CCR1 Receptor Antagonists CCR1, CCR3, CCRL2 ALDH1A1 911/4885PKM 4814/4885HSD17B3 1764/4885
US-20110230521-A1 Pyrazole Compounds As CCR1 Antagonists CCR1, CCR3, CCR4 ALDH1A1 846/4885PKM 3486/4885HSD17B3 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.